SCHEMBL2202365

SCHEMBL2202365

C=C(N)N(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608862 0.79 EHMT2 (0.40)
SCHEMBL20038137 0.75 PRMT3 (0.37)
SCHEMBL20038235 0.74 GRM4 (0.30)
SCHEMBL9473737 0.71 TDP1 (0.41)
SCHEMBL20037911 0.71
SCHEMBL1412540 0.70
SCHEMBL9453859 0.69
SCHEMBL1848524 0.69
SCHEMBL2376776 0.69
SCHEMBL612658 0.69 EHMT2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4655970-A ONE STEP CIBA-GEIGY AG (CH) 1987-04-07 US claimed
US-4393007-A ONE STEP PRODUCTION OF ANTHRAQUINONE DYES FROM 1-NITRO-ANTHRAQUINONE CIBA-GEIGY AG (CH) 1983-07-12 US claimed
US-12559592-B2 Branched amorphous polyamide (co)polymers and methods of making and using same 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-24 US disclosed
US-20230167243-A1 BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME 3M INNOVATIVE PROPERTIES COMPANY 2023-06-01 US disclosed
EP-4136185-A1 BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME 3M Innovative Properties Company (US) 2023-02-22 EP disclosed
WO-2021209895-A1 BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-10-21 WO disclosed
US-7977342-B2 HCV inhibiting bi-cyclic pyrimidines TIBOTEC-VIRCO VIROLOGY BVBA (BE) 2011-07-12 US disclosed
EP-1608631-A4 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGF BETA SCIOS INC (US) 2008-08-20 EP disclosed
US-20070155716-A1 HCV INHIBITING BI-CYCLIC PYRIMIDINES TIBOTEC PHARMACEUTICALS LTD. (IE) 2007-07-05 US disclosed
US-7223766-B2 Bi-cyclic pyrimidine inhibitors of TGFβ SCIOS, INC. (US) 2007-05-29 US disclosed
EP-1608631-A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGF BETA SCIOS INC. (US) 2005-12-28 EP disclosed
WO-2005077906-A1 NOVEL GUANIDINYL-SUBSTITUTED HYDROXY-6-PHENYLPHENENTHRIDINES AS EFFECTIVE PHOSPHODIESTERASE (PDE) 4 INHIBITORS ALTANA PHARMA AG (DE) 2005-08-25 WO disclosed
US-20050004143-A1 Bi-cyclic pyrimidine inhibitors of TGFbeta SCIOS, INC. 2005-01-06 US disclosed
WO-2004087056-A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ SCIOS INC. (US) 2004-10-14 WO disclosed
EP-0836613-A1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1998-04-22 EP disclosed
WO-1996040707-A1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS GENSIA SICOR (US) 1996-12-19 WO disclosed
US-4655970-A ONE STEP CIBA-GEIGY AG (CH) 1987-04-07 US disclosed
EP-0103381-A1 Substituted anthra(1,9-cd)pyrazol-6(2H)-ones WARNER-LAMBERT COMPANY (US) 1984-03-21 EP disclosed
US-4393007-A ONE STEP PRODUCTION OF ANTHRAQUINONE DYES FROM 1-NITRO-ANTHRAQUINONE CIBA-GEIGY AG (CH) 1983-07-12 US disclosed